J B Chemicals & Pharmaceuticals holds 50th AGM
J B Chemicals & Pharmaceuticals Limited held its 50th Annual General Meeting on June 17, 2026, via video conference. Shareholders approved the audited financial statements for FY26, confirmed an interim dividend of ₹12.70 per share, and declared a final dividend of ₹9.30 per share. The meeting, chaired by Mr. Arun Duggal, saw the re-appointment of a director and addressed shareholder queries.
*this image is generated using AI for illustrative purposes only.
J B Chemicals & Pharmaceuticals Limited conducted its 50th Annual General Meeting on June 17, 2026, via video conference. The meeting was held in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholders approved the adoption of audited financial statements for the year ended March 31, 2026, confirmed an interim dividend of ₹12.70 per share, and declared a final dividend of ₹9.30 per share.
The remote e-voting process commenced on June 14, 2026, and concluded on June 16, 2026. The Board appointed Mr. Rajesh Parekh and Ms. Aishwarya Parekh as scrutinizers to oversee the voting process. A total of 74,579 shareholders were on record as of the cut-off date, with 60 members present in person through VC/OAVM. The meeting was chaired by Mr. Arun Duggal.
Voting Results Summary
| Resolution Description | Votes For | Votes Against | % For |
|---|---|---|---|
| Adoption of Financial Statements | 134,006,581 | 23 | 100.00 |
| Confirmation of Interim Dividend | 134,028,537 | 23 | 100.00 |
| Declaration of Final Dividend | 134,028,512 | 48 | 100.00 |
| Re-appointment of Director | 133,790,983 | 217,055 | 99.84 |
Meeting Details
| Particulars | Details |
|---|---|
| Meeting Type | 50th Annual General Meeting |
| Date | June 17, 2026 |
| Time | 3.00 P.M. IST |
| Mode | Video Conference (VC) / Other Audio Visual Means (OAVM) |
| Chairman | Mr. Arun Duggal |
| Total Shareholders on Record | 74,579 |
The resolutions were passed with the requisite majority. Mr. Kaushal Singh Solanki, Chief Financial Officer, addressed queries from shareholders regarding the company's accounts and operations. The Statutory Auditors' Report and the Secretarial Audit Report contained no qualifications or adverse observations.
Historical Stock Returns for J B Chemicals and Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.23% | -2.63% | +3.21% | +22.75% | +27.46% | +186.56% |
How will the total dividend payout of ₹22.00 per share impact J B Chemicals' capital allocation strategy for FY2027?
What strategic priorities did management outline for the upcoming fiscal year during the shareholder Q&A session?
Given the clean audit reports, what are the company's key growth drivers and expansion plans for the post-2026 period?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
